Cargando…

Unraveling the Antioxidant Capacity of Spatholobi caulis in Nonalcoholic Fatty Liver Disease: A Multiscale Network Approach Integrated with Experimental Validation

Nonalcoholic fatty liver disease (NAFLD) is a global health problem that is closely associated with obesity and metabolic syndrome. Spatholobi caulis (SC) is a herbal medicine with potential hepatoprotective effects; however, its active compounds and underlying mechanisms have not been fully explore...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bae, Su-Jin, Lee, Won-Yung, Bak, Seon-Been, Kim, Young-Eun, Kim, Min-Jin, Kim, Young-Woo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215237/ https://www.ncbi.nlm.nih.gov/pubmed/37237962 http://dx.doi.org/10.3390/antiox12051097

Ejemplares similares

Coordination of AMPK and YAP by Spatholobi Caulis and Procyanidin B2 Provides Antioxidant Effects In Vitro and In Vivo
por: Bae, Su-Jin, et al.
Publicado: (2022)

Improved Adsorption of Tetracycline in Water by a Modified Caulis spatholobi Residue Biochar
por: Fan, Zheng, et al.
Publicado: (2022)

A Method to Study the Distribution Patterns for Metabolites in Xylem and Phloem of Spatholobi Caulis
por: Mei, Yuqi, et al.
Publicado: (2019)

Pharmacodynamic Material Basis and Potential Mechanism Study of Spatholobi Caulis in Reversing Osteoporosis
por: Xiao, Jianpeng, et al.
Publicado: (2023)

DNA Barcoding Identification of Kadsurae Caulis and Spatholobi Caulis Based on Internal Transcribed Spacer 2 Region and Secondary Structure Prediction
por: Yu, Xiaoxue, et al.
Publicado: (2016)

Caulis Spatholobi Ameliorates Obesity through Activating Brown Adipose Tissue and Modulating the Composition of Gut Microbiota
por: Zhang, Chuanhai, et al.
Publicado: (2019)

Molecular Mechanism of Caulis Spatholobi in the Treatment of Chronic Myeloid Leukemia based on Network Pharmacology and Experimental Verification
por: Wu, Yanchun, et al.
Publicado: (2023)

3D microfluidic in vitro model and bioinformatics integration to study the effects of Spatholobi Caulis tannin in cervical cancer
por: Wang, Nijia, et al.
Publicado: (2018)

The Pharmacological Effects of Spatholobi Caulis Tannin in Cervical Cancer and Its Precise Therapeutic Effect on Related circRNA
por: Wang, Nijia, et al.
Publicado: (2019)

Unveiling Potential Mechanisms of Spatholobi Caulis against Lung Metastasis of Malignant Tumor by Network Pharmacology and Molecular Docking
por: Xie, Feiyu, et al.
Publicado: (2022)

Effects of Caulis Spatholobi Polysaccharide on Immunity, Intestinal Mucosal Barrier Function, and Intestinal Microbiota in Cyclophosphamide-Induced Immunosuppressive Chickens
por: Cui, Yao, et al.
Publicado: (2022)

Study on the Hepatoprotection of Schisandra chinensis Caulis Polysaccharides in Nonalcoholic Fatty Liver Disease in Rats Based on Metabolomics
por: Feng, Yanbo, et al.
Publicado: (2021)

Angelica gigas NAKAI and Its Active Compound, Decursin, Inhibit Cellular Injury as an Antioxidant by the Regulation of AMP-Activated Protein Kinase and YAP Signaling
por: Song, Yu-Rim, et al.
Publicado: (2022)

Clinical Patterns and Outcome of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease
por: Ahn, Seon Young, et al.
Publicado: (2020)

Bambusae caulis in Liquamen Suppresses the Expression of Thymus and Activation-Regulated Chemokine and Macrophage-Derived Chemokine in Human Keratinocytes due to Antioxidant Effect
por: Qi, Xu-Feng, et al.
Publicado: (2012)

Impact of Visceral Fat on the Metabolic Syndrome and Nonalcoholic Fatty Liver Disease
por: Jeong, Seul-Ki, et al.
Publicado: (2008)

Vasorelaxant Effect of Trachelospermi caulis Extract on Rat Mesenteric Resistance Arteries
por: Haam, Chae Eun, et al.
Publicado: (2022)

Rapid Identification of Officinal Akebiae Caulis and Its Toxic Adulterant Aristolochiae Manshuriensis Caulis (Aristolochia manshuriensis) by Loop-Mediated Isothermal Amplification
por: Wu, Lan, et al.
Publicado: (2016)

Noninvasive predictors of nonalcoholic steatohepatitis in Korean patients with histologically proven nonalcoholic fatty liver disease
por: Kim, Young Seok, et al.
Publicado: (2013)

Association and Prediction of Subclinical Atherosclerosis by Nonalcoholic Fatty Liver Disease in Asymptomatic Patients
por: Bae, Ye Seul, et al.
Publicado: (2020)

The Influence of Metabolic Factors for Nonalcoholic Fatty Liver Disease in Women
por: Chung, Goh Eun, et al.
Publicado: (2015)

The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Cha, Ji-Young, et al.
Publicado: (2018)

Recent research trends and updates on nonalcoholic fatty liver disease
por: Yoo, Jeong-Ju, et al.
Publicado: (2019)

Hepatoprotective Effect and Synergism of Bisdemethoycurcumin against MCD Diet-Induced Nonalcoholic Fatty Liver Disease in Mice
por: Kim, Sung-Bae, et al.
Publicado: (2016)

Recent advances in nonalcoholic fatty liver disease metabolomics
por: Kim, Hwi Young
Publicado: (2021)

Association between small dense LDL levels and hepatic fibrosis in patients with nonalcoholic fatty liver disease
por: Young Kim, Sun, et al.
Publicado: (2022)

Discrimination of Nonalcoholic Steatohepatitis Using Transient Elastography in Patients with Nonalcoholic Fatty Liver Disease
por: Lee, Hye Won, et al.
Publicado: (2016)

Aqueous Extract of Bambusae Caulis in Taeniam Inhibits PMA-Induced Tumor Cell Invasion and Pulmonary Metastasis: Suppression of NF-κB Activation through ROS Signaling
por: Kim, Aeyung, et al.
Publicado: (2013)

Nonalcoholic Fatty Liver Disease and Diabetes: Part II: Treatment
por: Kim, Kyung-Soo, et al.
Publicado: (2019)

KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
por: Kang, Seong Hee, et al.
Publicado: (2021)

Circulating miRNA is a useful diagnostic biomarker for nonalcoholic steatohepatitis in nonalcoholic fatty liver disease
por: Kim, Tae Hyung, et al.
Publicado: (2021)

Micronutrient Antioxidants and Nonalcoholic Fatty Liver Disease
por: Chen, Guanliang, et al.
Publicado: (2016)

Nonalcoholic fatty liver disease in obese and nonobese pediatric patients
por: Kim, Eun Jeong, et al.
Publicado: (2019)

Beware of the Potential Risks for Polygoni Multiflori Caulis-Induced Liver Injury
por: Kong, Wei-Song, et al.
Publicado: (2022)

Cytoprotective Effect of Bambusae caulis in Liquamen by Blocking Oxidative Stress in Hepatocytes
por: Yang, Ji Hye
Publicado: (2023)

Development and validation of a simple index system to predict nonalcoholic fatty liver disease
por: Park, Young Jin, et al.
Publicado: (2011)

Age-Related Changes in Antioxidative Enzyme Capacity in Tongue of Fischer 344 Rats
por: Baek, Min-Kwan, et al.
Publicado: (2016)

Hypoadiponectinemia and Insulin Resistance are Associated with Nonalcoholic Fatty Liver Disease
por: Yoon, Dokyoung, et al.
Publicado: (2005)

Validation of a Quantification Method for Curcumin Derivatives and Their Hepatoprotective Effects on Nonalcoholic Fatty Liver Disease
por: Lee, Young-Seob, et al.
Publicado: (2022)

Hepatoprotective Effect of Kombucha Tea in Rodent Model of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
por: Lee, Chanbin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kf824a3s9nbm3m08234914n7kn